DaVita EBITDA Margin 2010-2024 | DVA

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for DaVita (DVA) over the last 10 years. The current EBITDA margin for DaVita as of March 31, 2024 is .
DaVita EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2024-03-31 $12.34B $2.53B 20.50%
2023-12-31 $12.14B $2.35B 19.34%
2023-09-30 $11.91B $2.21B 18.58%
2023-06-30 $11.74B $2.04B 17.34%
2023-03-31 $11.67B $2.05B 17.57%
2022-12-31 $11.61B $2.07B 17.84%
2022-09-30 $11.64B $2.19B 18.77%
2022-06-30 $11.63B $2.32B 19.99%
2022-03-31 $11.62B $2.38B 20.49%
2021-12-31 $11.62B $2.48B 21.32%
2021-09-30 $11.58B $2.46B 21.21%
2021-06-30 $11.57B $2.41B 20.80%
2021-03-31 $11.53B $2.31B 20.06%
2020-12-31 $11.55B $2.33B 20.13%
2020-09-30 $11.54B $2.40B 20.82%
2020-06-30 $11.52B $2.34B 20.32%
2020-03-31 $11.49B $2.39B 20.80%
2019-12-31 $11.39B $2.26B 19.83%
2019-09-30 $11.31B $2.18B 19.27%
2019-06-30 $11.25B $2.08B 18.49%
2019-03-31 $11.30B $2.05B 18.16%
2018-12-31 $11.40B $2.12B 18.55%
2018-09-30 $11.36B $1.91B 16.78%
2018-06-30 $11.28B $2.07B 18.36%
2018-03-31 $11.09B $2.08B 18.72%
2017-12-31 $10.88B $2.59B 23.81%
2017-09-30 $7.77B $2.96B 38.09%
2017-06-30 $8.74B $3.36B 38.48%
2017-03-31 $9.76B $3.28B 33.62%
2016-12-31 $10.71B $2.75B 25.67%
2016-09-30 $10.76B $2.42B 22.46%
2016-06-30 $10.56B $2.09B 19.77%
2016-03-31 $10.28B $2.22B 21.58%
2015-12-31 $9.98B $1.77B 17.77%
2015-09-30 $13.58B $2.01B 14.77%
2015-06-30 $13.30B $1.92B 14.44%
2015-03-31 $13.04B $1.91B 14.66%
2014-12-31 $12.80B $2.41B 18.80%
2014-09-30 $12.53B $2.42B 19.34%
2014-06-30 $12.28B $2.35B 19.12%
2014-03-31 $11.98B $2.37B 19.79%
2013-12-31 $11.77B $2.08B 17.67%
2013-09-30 $11.18B $1.95B 17.48%
2013-06-30 $10.13B $1.87B 18.42%
2013-03-31 $9.17B $1.54B 16.77%
2012-12-31 $8.19B $1.64B 20.04%
2012-09-30 $7.46B $1.57B 21.05%
2012-06-30 $7.27B $1.54B 21.13%
2012-03-31 $7.02B $1.52B 21.68%
2011-12-31 $6.73B $1.42B 21.13%
2011-09-30 $6.41B $1.31B 20.41%
2011-06-30 $6.30B $1.24B 19.61%
2011-03-31 $6.22B $1.23B 19.69%
2010-12-31 $6.22B $1.23B 19.74%
2010-09-30 $6.36B $1.21B 19.05%
2010-06-30 $6.28B $1.20B 19.08%
2010-03-31 $6.21B $1.19B 19.17%
2009-12-31 $6.10B $1.17B 19.16%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $12.150B $12.140B
DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services. DaVita's Dialysis and related lab services business segment provides inpatient as well as outpatient dialysis services, routine laboratory testing for ESRD patients and management services to outpatient dialysis centers. The company's other ancillary services and strategic initiatives segment includes its international dialysis services, pharmacy services, infusion therapy services, disease management services, vascular access services, ESRD clinical research programs and physician services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.537B 10.61
Quest Diagnostics (DGX) United States $15.695B 16.22
Encompass Health (EHC) United States $8.507B 21.78
Chemed (CHE) United States $8.408B 26.06
Elanco Animal Health (ELAN) United States $8.297B 21.53
Option Care Health (OPCH) United States $5.048B 19.11
RadNet (RDNT) United States $4.325B 90.06
Amedisys (AMED) United States $3.145B 22.28
Astrana Health (ASTH) United States $2.239B 30.28
LifeStance Health (LFST) United States $2.179B 0.00
Addus HomeCare (ADUS) United States $1.827B 26.14
U.S Physical Therapy (USPH) United States $1.534B 41.06
Pennant (PNTG) United States $0.706B 37.29
Aveanna Healthcare Holdings (AVAH) United States $0.539B 0.00
Atai Life Sciences (ATAI) Germany $0.270B 0.00
Daxor (DXR) United States $0.045B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.026B 0.00
ATI Physical Therapy (ATIP) United States $0.021B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Ontrak (OTRK) United States $0.013B 0.00
Novo Integrated Sciences (NVOS) United States $0.010B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00